Skip to main content
Top

27-09-2024 | Human Immunodeficiency Virus | Original Paper

Interest in Oral Pre-exposure Prophylaxis Among Men Who Have Sex with Men and Transfeminine Persons in HPTN 075, a Multi-center HIV Prevention Study in Sub-Saharan Africa (2015–2017)

Authors: Joseph O. Orinda, Victor Mudhune, Valarie Opollo, Calvin Mbeda, Ravindre Panchia, erica hamilton, Sufia Dadabhai, Doerieyah Reynolds, Theodorus G. M. Sandfort, the HPTN 075 study team

Published in: AIDS and Behavior

Login to get access

Abstract

Use of oral pre-exposure prophylaxis (O-PrEP) for HIV prevention has not been fully utilized in sub-Saharan Africa, especially among key populations with high HIV incidence and prevalence, including men who have sex with men (MSM) and transgender women (TGW). We examined correlates of interest in O-PrEP among participants in the HIV Prevention Trials Network (HPTN) Study 075, a prospective cohort study, conducted between 2015 and 2017, across 4 sites in Kenya, Malawi, and South Africa. The study included persons assigned male sex at birth, between 18 and 44 years of age, who reported anal intercourse with a man in the past 3 months. Interest in O-PrEP and potential correlates were assessed among 297 participants who were HIV negative. 52% of the participants reported being aware of PrEP and 73% indicated interest in PrEP once informed about it. PrEP interest was not significantly associated with any of the surveyed demographic or psychosocial variables except study site. Our findings suggest a broad and general interest in O-PrEP among MSM and TGW in sub-Saharan Africa, despite relatively low awareness. While the situation around PrEP will have changed in the included countries, major questions about successful implementation still need to be addressed.
Literature
4.
go back to reference Fonner VA, Dalglish SL, Kennedy CE, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973.PubMedCrossRef Fonner VA, Dalglish SL, Kennedy CE, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973.PubMedCrossRef
5.
go back to reference World Health Organization (2015) Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). World Health Organization World Health Organization (2015) Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). World Health Organization
7.
go back to reference Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.PubMedPubMedCentralCrossRef Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.PubMedPubMedCentralCrossRef
8.
go back to reference Antoni G, Tremblay C, Delaugerre C, et al. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Lancet HIV. 2020;7(2):e113-20.PubMedCrossRef Antoni G, Tremblay C, Delaugerre C, et al. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Lancet HIV. 2020;7(2):e113-20.PubMedCrossRef
9.
go back to reference McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.PubMedPubMedCentralCrossRef McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.PubMedPubMedCentralCrossRef
11.
go back to reference Molina J-M, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New Engl J Med. 2015;373(23):2237–46.PubMedCrossRef Molina J-M, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New Engl J Med. 2015;373(23):2237–46.PubMedCrossRef
12.
go back to reference Murchu EO, Marshall L, Teljeur C, et al. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 2022;12(5):e048478.CrossRef Murchu EO, Marshall L, Teljeur C, et al. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 2022;12(5):e048478.CrossRef
13.
go back to reference Kimani M, van der Elst EM, Chiro O, et al. Pr EP interest and HIV-1 incidence among MSM and transgender women in coastal Kenya. J Int AIDS Soc. 2019;22(6):e25323.PubMedPubMedCentralCrossRef Kimani M, van der Elst EM, Chiro O, et al. Pr EP interest and HIV-1 incidence among MSM and transgender women in coastal Kenya. J Int AIDS Soc. 2019;22(6):e25323.PubMedPubMedCentralCrossRef
14.
go back to reference Yi S, Tuot S, Mwai GW, et al. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low‐and middle‐income countries: a systematic review and meta‐analysis. J Int AIDS Soc. 2017;20(1):21580.PubMedPubMedCentralCrossRef Yi S, Tuot S, Mwai GW, et al. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low‐and middle‐income countries: a systematic review and meta‐analysis. J Int AIDS Soc. 2017;20(1):21580.PubMedPubMedCentralCrossRef
15.
go back to reference Ogunbajo A, Leblanc NM, Kushwaha S, et al. Knowledge and acceptability of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Ghana. AIDS Care. 2020;32(3):330–6.PubMedCrossRef Ogunbajo A, Leblanc NM, Kushwaha S, et al. Knowledge and acceptability of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Ghana. AIDS Care. 2020;32(3):330–6.PubMedCrossRef
16.
go back to reference Sithole B. HIV prevention needs for men who have sex with men in Swaziland. Afr J AIDS Res. 2017;16(4):315–20.PubMedCrossRef Sithole B. HIV prevention needs for men who have sex with men in Swaziland. Afr J AIDS Res. 2017;16(4):315–20.PubMedCrossRef
17.
go back to reference Coulaud PJ, Sagaon-Teyssier L, M’Madi Mrenda B, et al. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324—expertise France). Trop Med Int Health. 2018;23(10):1084–91.PubMedCrossRef Coulaud PJ, Sagaon-Teyssier L, M’Madi Mrenda B, et al. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324—expertise France). Trop Med Int Health. 2018;23(10):1084–91.PubMedCrossRef
18.
go back to reference Camlin CS, Koss CA, Getahun M, et al. Understanding demand for PrEP and early experiences of PrEP use among young adults in rural Kenya and Uganda: a qualitative study. AIDS Behav. 2020;24(7):2149–62.PubMedPubMedCentralCrossRef Camlin CS, Koss CA, Getahun M, et al. Understanding demand for PrEP and early experiences of PrEP use among young adults in rural Kenya and Uganda: a qualitative study. AIDS Behav. 2020;24(7):2149–62.PubMedPubMedCentralCrossRef
19.
go back to reference Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDs. 2013;27(4):248–54.PubMedPubMedCentralCrossRef Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDs. 2013;27(4):248–54.PubMedPubMedCentralCrossRef
20.
go back to reference Young I, Flowers P, McDaid LM. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ Open. 2014;4(11):e005717.PubMedPubMedCentralCrossRef Young I, Flowers P, McDaid LM. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ Open. 2014;4(11):e005717.PubMedPubMedCentralCrossRef
21.
go back to reference Ogunbajo A, Iwuagwu S, Williams R, Biello K, Mimiaga MJ. Awareness, willingness to use, and history of HIV PrEP use among gay, bisexual, and other men who have sex with men in Nigeria. PLoS ONE. 2019;14(12):e0226384.PubMedPubMedCentralCrossRef Ogunbajo A, Iwuagwu S, Williams R, Biello K, Mimiaga MJ. Awareness, willingness to use, and history of HIV PrEP use among gay, bisexual, and other men who have sex with men in Nigeria. PLoS ONE. 2019;14(12):e0226384.PubMedPubMedCentralCrossRef
22.
go back to reference Mbeda C, Ogendo A, Lando R, et al. Healthcare-related stigma among men who have sex with men and transgender women in sub-saharan Africa participating in HIV Prevention Trials Network (HPTN) 075 study. AIDS Care. 2020;32(8):1052–60.PubMedPubMedCentralCrossRef Mbeda C, Ogendo A, Lando R, et al. Healthcare-related stigma among men who have sex with men and transgender women in sub-saharan Africa participating in HIV Prevention Trials Network (HPTN) 075 study. AIDS Care. 2020;32(8):1052–60.PubMedPubMedCentralCrossRef
23.
go back to reference O’Malley G, Barnabee G, Mugwanya K. Scaling-up PrEP delivery in Sub-Saharan Africa: what can we learn from the scale-up of ART? Cur HIV-AIDS Rep. 2019;16(2):141–50.CrossRef O’Malley G, Barnabee G, Mugwanya K. Scaling-up PrEP delivery in Sub-Saharan Africa: what can we learn from the scale-up of ART? Cur HIV-AIDS Rep. 2019;16(2):141–50.CrossRef
25.
go back to reference Masyuko S, Mukui I, Njathi O, et al. Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study. Sex Health. 2018;15(6):578–86.PubMedPubMedCentralCrossRef Masyuko S, Mukui I, Njathi O, et al. Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study. Sex Health. 2018;15(6):578–86.PubMedPubMedCentralCrossRef
26.
go back to reference Kabaghe AN, Singano V, Payne D, et al. Awareness of and willingness to use oral pre-exposure prophylaxis (PrEP) for HIV prevention among sexually active adults in Malawi: results from the 2020 Malawi population-based HIV impact assessment. BMC Infect Dis. 2023;23(1):712.PubMedPubMedCentralCrossRef Kabaghe AN, Singano V, Payne D, et al. Awareness of and willingness to use oral pre-exposure prophylaxis (PrEP) for HIV prevention among sexually active adults in Malawi: results from the 2020 Malawi population-based HIV impact assessment. BMC Infect Dis. 2023;23(1):712.PubMedPubMedCentralCrossRef
27.
go back to reference Sandfort TG, Hamilton L, Marais E. The feasibility of recruiting and retaining men who have sex with men and transgender women in a multinational prospective HIV prevention research cohort study in Sub-Saharan Africa (HPTN 075). J Int AIDS Soc. 2020;23:e25600.PubMedPubMedCentralCrossRef Sandfort TG, Hamilton L, Marais E. The feasibility of recruiting and retaining men who have sex with men and transgender women in a multinational prospective HIV prevention research cohort study in Sub-Saharan Africa (HPTN 075). J Int AIDS Soc. 2020;23:e25600.PubMedPubMedCentralCrossRef
28.
go back to reference Manea L, Gilbody S, McMillan D. A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiat. 2015;37(1):67–75.CrossRef Manea L, Gilbody S, McMillan D. A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiat. 2015;37(1):67–75.CrossRef
29.
go back to reference DeHart DD, Birkimer JC. Trying to practice safer sex: development of the sexual risks scale. J Sex Res. 1997;34(1):11–25.CrossRef DeHart DD, Birkimer JC. Trying to practice safer sex: development of the sexual risks scale. J Sex Res. 1997;34(1):11–25.CrossRef
30.
go back to reference Younge SN, Salem D, Bybee D. Risk revisited: the perception of HIV risk in a community sample of low-income African American women. J Black Psychol. 2010;6(1):49–74.CrossRef Younge SN, Salem D, Bybee D. Risk revisited: the perception of HIV risk in a community sample of low-income African American women. J Black Psychol. 2010;6(1):49–74.CrossRef
31.
go back to reference Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–29.PubMedCrossRef Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–29.PubMedCrossRef
32.
go back to reference Jeyaseelan L, Kumar S, Mohanraj R, et al. Assessing HIV/AIDS stigma in South India: validation and abridgement of the Berger HIV stigma scale. Aids Behav. 2013;17(1):434–43.PubMedPubMedCentralCrossRef Jeyaseelan L, Kumar S, Mohanraj R, et al. Assessing HIV/AIDS stigma in South India: validation and abridgement of the Berger HIV stigma scale. Aids Behav. 2013;17(1):434–43.PubMedPubMedCentralCrossRef
33.
go back to reference Were D, Musau A, Mugambi M, et al. An implementation model for scaling up oral pre-exposure prophylaxis in Kenya: Jilinde project. Gates Open Res. 2021;5:113.PubMedPubMedCentralCrossRef Were D, Musau A, Mugambi M, et al. An implementation model for scaling up oral pre-exposure prophylaxis in Kenya: Jilinde project. Gates Open Res. 2021;5:113.PubMedPubMedCentralCrossRef
34.
go back to reference Yi S, Tuot S, Mwai GW, Ngin C, Chhim K, Pal K, Igbinedion E, Holland P, Choub SC, Mburu G. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low‐and middle‐income countries: a systematic review and meta‐analysis. J Int Aids Soc. 2017;20(1):21580.PubMedPubMedCentralCrossRef Yi S, Tuot S, Mwai GW, Ngin C, Chhim K, Pal K, Igbinedion E, Holland P, Choub SC, Mburu G. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low‐and middle‐income countries: a systematic review and meta‐analysis. J Int Aids Soc. 2017;20(1):21580.PubMedPubMedCentralCrossRef
35.
go back to reference Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review. Adv Ther. 2020;37(5):1778–811.PubMedPubMedCentralCrossRef Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review. Adv Ther. 2020;37(5):1778–811.PubMedPubMedCentralCrossRef
36.
go back to reference Pillay Y (2018) Challenges of South Africa’s sex worker PrEP programme: lessons learned, moving towards to other key populations. Paper presented at: 22nd international AIDS conference. Pillay Y (2018) Challenges of South Africa’s sex worker PrEP programme: lessons learned, moving towards to other key populations. Paper presented at: 22nd international AIDS conference.
37.
go back to reference Irungu EM, Mugwanya KK, Mugo NR, et al. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial. Lancet Glob Health. 2021;9(12):e1730-9.PubMedPubMedCentralCrossRef Irungu EM, Mugwanya KK, Mugo NR, et al. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial. Lancet Glob Health. 2021;9(12):e1730-9.PubMedPubMedCentralCrossRef
38.
go back to reference Olakunde BO, Folala-Anoemuah Y, Ujam C, et al. Awareness and uptake of oral pre-exposure prophylaxis among adolescent and young key populations in Nigeria: a secondary data analysis of the 2020 integrated biological & behavioural surveillance survey. AIDS Care. 2024;36(1):146–52.PubMedCrossRef Olakunde BO, Folala-Anoemuah Y, Ujam C, et al. Awareness and uptake of oral pre-exposure prophylaxis among adolescent and young key populations in Nigeria: a secondary data analysis of the 2020 integrated biological & behavioural surveillance survey. AIDS Care. 2024;36(1):146–52.PubMedCrossRef
39.
go back to reference Emmanuel G, Folayan M, Undelikwe G, et al. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria. BMC Public Health. 2020;20:69.PubMedPubMedCentralCrossRef Emmanuel G, Folayan M, Undelikwe G, et al. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria. BMC Public Health. 2020;20:69.PubMedPubMedCentralCrossRef
40.
go back to reference Mpunga E, Persaud N, Akolo C, et al. Readiness for use of HIV preexposure prophylaxis among men who have sex with men in Malawi: qualitative focus group and interview study. JMIR Public Health Surveill. 2021;7(10):e26177.PubMedPubMedCentralCrossRef Mpunga E, Persaud N, Akolo C, et al. Readiness for use of HIV preexposure prophylaxis among men who have sex with men in Malawi: qualitative focus group and interview study. JMIR Public Health Surveill. 2021;7(10):e26177.PubMedPubMedCentralCrossRef
41.
go back to reference Karuga RN, Njenga SN, Mulwa R, et al. How I wish this thing was initiated 100 years ago! Willingness to take daily oral pre-exposure prophylaxis among men who have sex with men in Kenya. PLoS ONE. 2016;11(4):e0151716.PubMedPubMedCentralCrossRef Karuga RN, Njenga SN, Mulwa R, et al. How I wish this thing was initiated 100 years ago! Willingness to take daily oral pre-exposure prophylaxis among men who have sex with men in Kenya. PLoS ONE. 2016;11(4):e0151716.PubMedPubMedCentralCrossRef
42.
go back to reference Sandfort TGM, Kreniske P, Mbeda C, et al. Interest in I-PrEP and willingness to participate in clinical trials among men and transfeminine persons who have sex with men in Sub-saharan Africa: quantitative and qualitative findings from HPTN 075. AIDS Behav. 2024;28:2361–77.PubMedCrossRef Sandfort TGM, Kreniske P, Mbeda C, et al. Interest in I-PrEP and willingness to participate in clinical trials among men and transfeminine persons who have sex with men in Sub-saharan Africa: quantitative and qualitative findings from HPTN 075. AIDS Behav. 2024;28:2361–77.PubMedCrossRef
43.
go back to reference Bailey RC, Kimani M, Kabuti R, et al. URCHOICE: preferences for Pre-exposure Prophylaxis (PrEP) options for HIV prevention among Kenyan men who have sex with men and transgender women in Nairobi, Kisumu and the coast. AIDS Behav. 2023;27(1):25–36.PubMedCrossRef Bailey RC, Kimani M, Kabuti R, et al. URCHOICE: preferences for Pre-exposure Prophylaxis (PrEP) options for HIV prevention among Kenyan men who have sex with men and transgender women in Nairobi, Kisumu and the coast. AIDS Behav. 2023;27(1):25–36.PubMedCrossRef
44.
go back to reference Personal communications with Yamikani Chimwaza, Richard Kaplan, and Joseph Orinda, respectively. Personal communications with Yamikani Chimwaza, Richard Kaplan, and Joseph Orinda, respectively.
45.
go back to reference Wahome EW, Graham SM, Thiong’o AN, et al. PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men. EClinicalMedicine. 2020;26:100541.PubMedPubMedCentralCrossRef Wahome EW, Graham SM, Thiong’o AN, et al. PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men. EClinicalMedicine. 2020;26:100541.PubMedPubMedCentralCrossRef
46.
go back to reference Bekker LG, Giovenco D, Baral S, et al. Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women. S Afr J HIV Med. 2022;23(1):a1405.CrossRef Bekker LG, Giovenco D, Baral S, et al. Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women. S Afr J HIV Med. 2022;23(1):a1405.CrossRef
47.
go back to reference Graham SM, Okall DO, Mehta SD, et al. Challenges with PrEP uptake and adherence among gay, bisexual, and other men who have sex with men in Kisumu, Kenya. AIDS Behav. 2023;27(4):1234–47.PubMedCrossRef Graham SM, Okall DO, Mehta SD, et al. Challenges with PrEP uptake and adherence among gay, bisexual, and other men who have sex with men in Kisumu, Kenya. AIDS Behav. 2023;27(4):1234–47.PubMedCrossRef
49.
go back to reference Karim SSA, Baxter C. HIV pre-exposure prophylaxis implementation in Africa: some early lessons. Lancet Glob Health. 2021;9(12):e1634–5.PubMedCrossRef Karim SSA, Baxter C. HIV pre-exposure prophylaxis implementation in Africa: some early lessons. Lancet Glob Health. 2021;9(12):e1634–5.PubMedCrossRef
50.
go back to reference Celum CL, Delany-Moretlwe S, Baeten JM, et al. HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019;22:e25298.PubMedPubMedCentralCrossRef Celum CL, Delany-Moretlwe S, Baeten JM, et al. HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019;22:e25298.PubMedPubMedCentralCrossRef
51.
go back to reference Koss CA, Charlebois ED, Ayieko J, et al. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. Lancet HIV. 2020;7(4):e249–61.PubMedPubMedCentralCrossRef Koss CA, Charlebois ED, Ayieko J, et al. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. Lancet HIV. 2020;7(4):e249–61.PubMedPubMedCentralCrossRef
52.
go back to reference Ortblad KF, Mogere P, Roche S, et al. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation. BMC Health Serv Res. 2020;20(1):1–9.CrossRef Ortblad KF, Mogere P, Roche S, et al. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation. BMC Health Serv Res. 2020;20(1):1–9.CrossRef
Metadata
Title
Interest in Oral Pre-exposure Prophylaxis Among Men Who Have Sex with Men and Transfeminine Persons in HPTN 075, a Multi-center HIV Prevention Study in Sub-Saharan Africa (2015–2017)
Authors
Joseph O. Orinda
Victor Mudhune
Valarie Opollo
Calvin Mbeda
Ravindre Panchia
erica hamilton
Sufia Dadabhai
Doerieyah Reynolds
Theodorus G. M. Sandfort
the HPTN 075 study team
Publication date
27-09-2024
Publisher
Springer US
Published in
AIDS and Behavior
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-024-04514-9

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more